High Level Group on Research and Development

High Level Group on Research and Development
Name	High Level Group on Research and Development
Formation	1990s
Type	Advisory body
Headquarters	Brussels
Region served	European Union
Leader title	Chair
Parent organization	European Commission

Contents

High Level Group on Research and Development

The High Level Group on Research and Development was an advisory panel convened to shape European Commission policy on research and development and innovation across the European Union. It brought together senior figures from institutions such as the European Parliament, European Council, Organisation for Economic Co-operation and Development, and national ministries to produce policy advice influencing programmes like Horizon 2020, Framework Programme and initiatives linked to the Lisbon Strategy. The Group's outputs intersected with stakeholders including the World Bank, United Nations Educational, Scientific and Cultural Organization, and major research organisations such as CERN, Max Planck Society, and CNRS.

Background and Establishment

The Group was established amid policy debates involving the Delors Commission, Jacques Delors, and national leaders including Helmut Kohl, John Major, and Giorgio Napolitano seeking to strengthen Europe's competitiveness against United States, Japan, and emerging South Korea science systems. Early precursors included expert panels advising the European Research Area initiative and consultative bodies linked to the Maastricht Treaty and Treaty of Amsterdam. The Group's formation drew on advisory practice from institutions like the Royal Society, National Academy of Sciences (United States), Fraunhofer Society, and the European Science Foundation to advise on coherence between the European Investment Bank funding, national programmes such as those of Germany, France, Italy, Spain, and transnational projects like EUREKA.

Mandated by the European Commission Directorate-General for Research and Innovation, the Group aimed to provide strategic recommendations on thematic priorities, funding mechanisms, and governance models for European research funding instruments. Objectives referenced international benchmarks such as the Lisbon Strategy competitiveness targets, the Barcelona European Council research intensity goals, and alignment with standards from bodies like the International Monetary Fund and Organisation for Economic Co-operation and Development. The Group's remit included advising on coordination with programmes administered by European Institute of Innovation and Technology, Joint Research Centre, and member-state agencies like the Engineering and Physical Sciences Research Council and Agence Nationale de la Recherche.

Membership typically comprised senior policymakers, chief executives, and prominent scholars drawn from institutions such as CERN, European Space Agency, Max Planck Society, CNRS, University of Oxford, Sorbonne University, ETH Zurich, Karolinska Institute, University of Cambridge, and industry leaders from corporations like Siemens, Philips, SAP SE, Airbus, Rolls-Royce Holdings. Chairs were often former ministers or commissioners with backgrounds in science policy akin to figures who served in the European Commission or national cabinets such as Margaret Thatcher-era advisers, Gaston Thorn, or Neil Kinnock. Governance processes mirrored advisory models used by the Royal Society, National Academy of Sciences (United States), and European Research Council panels, incorporating working groups on themes like nanotechnology, information society, and biomedical research with liaison to organisations including World Health Organization, European Medicines Agency, and European Patent Office.

The Group issued influential reports recommending increased funding targets consistent with the Barcelona European Council 3% GDP objective, restructuring of the Framework Programme into consolidated missions, and creation of instruments resembling the European Research Council. Reports emphasized transnational collaboration modeled on initiatives such as Human Genome Project, Large Hadron Collider, and cooperative networks similar to COST (European Cooperation in Science and Technology). Key recommendations included proposals for simplified grant procedures comparable to Horizon 2020 reforms, strengthened links to industrial policy championed by entities like European Industrial Research Management Association and integration with regional policy instruments like the Cohesion Fund and European Social Fund.

Several recommendations were adopted into successive EU programmes, influencing the architecture of Horizon 2020, the establishment of the European Research Council, and funding prioritisation in areas such as renewable energy aligned with policies led by Angela Merkel's cabinets in Germany and strategic priorities of President of the European Commission offices. Implementation involved coordination with national funding agencies including Austrian Science Fund, Swiss National Science Foundation, Research Council of Norway, the Science Foundation Ireland, and pan-European infrastructures like ESFRI. The Group's influence extended to bilateral research partnerships with United States Department of Energy, National Institutes of Health, Japan Science and Technology Agency, and multilateral projects with World Bank financing.

Critics pointed to perceived bias favoring large research institutions such as CERN, Max Planck Society, and legacy universities including University of Cambridge and Sorbonne University, and alleged underrepresentation of smaller states like Malta and sectors led by firms similar to Start-up Nation models. Controversies included debates over targets derived from the Lisbon Strategy and tensions with national sovereignty raised by politicians like Marine Le Pen and Viktor Orbán who contested perceived centralisation. Some stakeholder groups, including regional authorities represented by the Committee of the Regions and trade unions like European Trade Union Confederation, argued that social and regional cohesion concerns were insufficiently addressed, while patent policy proposals intersected with disputes involving the European Patent Office and interests represented in litigations before the Court of Justice of the European Union.

Category:European Union advisory bodies